Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats

Tauheed Ishrat, Kehkashan Parveen, Md Nasrul Hoda, Mohammad Badruzzaman Khan, Seema Yousuf, Mubeen Ahmad Ansari, Sofiyan Saleem, Fakhrul Islam

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Oxidative stress plays a crucial role in the progression of cognitive decline in Alzheimer's disease (AD). Considerable attention has been focused on increasing the internal antioxidant defenses in response to AD. This study was designed to examine and compare the pretreatment effects of Pycnogenol (PYC) and vitamin E (Vit E) on cognitive deficits and oxidative damage in the hippocampus and cerebral cortex of intracerebroventricular streptozotocin (ICV-STZ)-infused rats. Rats pretreated with PYC (10 mg/kg), Vit E (100 mg/kg), and vehicle (intraperitoneal; once daily for 3 weeks) were bilaterally injected with ICV-STZ (3 mg/kg), whereas sham rats received the same volume of vehicle. After 2 weeks of ICV-STZ infusion, rats were tested for cognitive performance using passive avoidance and water maze tasks, and then killed for biochemical assays. ICV-STZ induced significant declines in cognitive performance and choline acetyltransferase activity in the hippocampus, which were significantly attenuated with PYC and Vit E. Pretreatment with PYC and Vit E produced a significantly enhanced glutathione level and Na/K-ATPase activity and decreased thiobarbituric acid reactive substances and protein carbonyl. These findings suggest that PYC and Vit E may provide a promising approach for the treatment of oxidative stress-related neurodegeneration in conditions such as AD.

Original languageEnglish (US)
Pages (from-to)567-575
Number of pages9
JournalBehavioural Pharmacology
Volume20
Issue number7
DOIs
StatePublished - Oct 1 2009
Externally publishedYes

Fingerprint

Streptozocin
Vitamin E
Alzheimer Disease
Hippocampus
Oxidative Stress
Intraventricular Infusions
Choline O-Acetyltransferase
Thiobarbituric Acid Reactive Substances
Cerebral Cortex
Glutathione
Antioxidants
pycnogenols
Water
Proteins
Cognitive Dysfunction
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats. / Ishrat, Tauheed; Parveen, Kehkashan; Hoda, Md Nasrul; Khan, Mohammad Badruzzaman; Yousuf, Seema; Ansari, Mubeen Ahmad; Saleem, Sofiyan; Islam, Fakhrul.

In: Behavioural Pharmacology, Vol. 20, No. 7, 01.10.2009, p. 567-575.

Research output: Contribution to journalArticle

Ishrat, Tauheed ; Parveen, Kehkashan ; Hoda, Md Nasrul ; Khan, Mohammad Badruzzaman ; Yousuf, Seema ; Ansari, Mubeen Ahmad ; Saleem, Sofiyan ; Islam, Fakhrul. / Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats. In: Behavioural Pharmacology. 2009 ; Vol. 20, No. 7. pp. 567-575.
@article{34c89b9515e24ca398fa433b46f38c36,
title = "Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats",
abstract = "Oxidative stress plays a crucial role in the progression of cognitive decline in Alzheimer's disease (AD). Considerable attention has been focused on increasing the internal antioxidant defenses in response to AD. This study was designed to examine and compare the pretreatment effects of Pycnogenol (PYC) and vitamin E (Vit E) on cognitive deficits and oxidative damage in the hippocampus and cerebral cortex of intracerebroventricular streptozotocin (ICV-STZ)-infused rats. Rats pretreated with PYC (10 mg/kg), Vit E (100 mg/kg), and vehicle (intraperitoneal; once daily for 3 weeks) were bilaterally injected with ICV-STZ (3 mg/kg), whereas sham rats received the same volume of vehicle. After 2 weeks of ICV-STZ infusion, rats were tested for cognitive performance using passive avoidance and water maze tasks, and then killed for biochemical assays. ICV-STZ induced significant declines in cognitive performance and choline acetyltransferase activity in the hippocampus, which were significantly attenuated with PYC and Vit E. Pretreatment with PYC and Vit E produced a significantly enhanced glutathione level and Na/K-ATPase activity and decreased thiobarbituric acid reactive substances and protein carbonyl. These findings suggest that PYC and Vit E may provide a promising approach for the treatment of oxidative stress-related neurodegeneration in conditions such as AD.",
author = "Tauheed Ishrat and Kehkashan Parveen and Hoda, {Md Nasrul} and Khan, {Mohammad Badruzzaman} and Seema Yousuf and Ansari, {Mubeen Ahmad} and Sofiyan Saleem and Fakhrul Islam",
year = "2009",
month = "10",
day = "1",
doi = "10.1097/FBP.0b013e32832c7125",
language = "English (US)",
volume = "20",
pages = "567--575",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats

AU - Ishrat, Tauheed

AU - Parveen, Kehkashan

AU - Hoda, Md Nasrul

AU - Khan, Mohammad Badruzzaman

AU - Yousuf, Seema

AU - Ansari, Mubeen Ahmad

AU - Saleem, Sofiyan

AU - Islam, Fakhrul

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Oxidative stress plays a crucial role in the progression of cognitive decline in Alzheimer's disease (AD). Considerable attention has been focused on increasing the internal antioxidant defenses in response to AD. This study was designed to examine and compare the pretreatment effects of Pycnogenol (PYC) and vitamin E (Vit E) on cognitive deficits and oxidative damage in the hippocampus and cerebral cortex of intracerebroventricular streptozotocin (ICV-STZ)-infused rats. Rats pretreated with PYC (10 mg/kg), Vit E (100 mg/kg), and vehicle (intraperitoneal; once daily for 3 weeks) were bilaterally injected with ICV-STZ (3 mg/kg), whereas sham rats received the same volume of vehicle. After 2 weeks of ICV-STZ infusion, rats were tested for cognitive performance using passive avoidance and water maze tasks, and then killed for biochemical assays. ICV-STZ induced significant declines in cognitive performance and choline acetyltransferase activity in the hippocampus, which were significantly attenuated with PYC and Vit E. Pretreatment with PYC and Vit E produced a significantly enhanced glutathione level and Na/K-ATPase activity and decreased thiobarbituric acid reactive substances and protein carbonyl. These findings suggest that PYC and Vit E may provide a promising approach for the treatment of oxidative stress-related neurodegeneration in conditions such as AD.

AB - Oxidative stress plays a crucial role in the progression of cognitive decline in Alzheimer's disease (AD). Considerable attention has been focused on increasing the internal antioxidant defenses in response to AD. This study was designed to examine and compare the pretreatment effects of Pycnogenol (PYC) and vitamin E (Vit E) on cognitive deficits and oxidative damage in the hippocampus and cerebral cortex of intracerebroventricular streptozotocin (ICV-STZ)-infused rats. Rats pretreated with PYC (10 mg/kg), Vit E (100 mg/kg), and vehicle (intraperitoneal; once daily for 3 weeks) were bilaterally injected with ICV-STZ (3 mg/kg), whereas sham rats received the same volume of vehicle. After 2 weeks of ICV-STZ infusion, rats were tested for cognitive performance using passive avoidance and water maze tasks, and then killed for biochemical assays. ICV-STZ induced significant declines in cognitive performance and choline acetyltransferase activity in the hippocampus, which were significantly attenuated with PYC and Vit E. Pretreatment with PYC and Vit E produced a significantly enhanced glutathione level and Na/K-ATPase activity and decreased thiobarbituric acid reactive substances and protein carbonyl. These findings suggest that PYC and Vit E may provide a promising approach for the treatment of oxidative stress-related neurodegeneration in conditions such as AD.

UR - http://www.scopus.com/inward/record.url?scp=70349679319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349679319&partnerID=8YFLogxK

U2 - 10.1097/FBP.0b013e32832c7125

DO - 10.1097/FBP.0b013e32832c7125

M3 - Article

VL - 20

SP - 567

EP - 575

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 7

ER -